| Product Code: ETC6241176 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahamas COVID-19 Infection Market Overview |
3.1 Bahamas Country Macro Economic Indicators |
3.2 Bahamas COVID-19 Infection Market Revenues & Volume, 2021 & 2031F |
3.3 Bahamas COVID-19 Infection Market - Industry Life Cycle |
3.4 Bahamas COVID-19 Infection Market - Porter's Five Forces |
3.5 Bahamas COVID-19 Infection Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Bahamas COVID-19 Infection Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Bahamas COVID-19 Infection Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Bahamas COVID-19 Infection Market Revenues & Volume Share, By Dosage Forms, 2021 & 2031F |
3.9 Bahamas COVID-19 Infection Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Bahamas COVID-19 Infection Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Bahamas COVID-19 Infection Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Bahamas COVID-19 Infection Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing tourism activity in the Bahamas |
4.2.2 Government initiatives to promote healthcare infrastructure and testing capabilities |
4.2.3 Rising awareness about the importance of testing and vaccination for COVID-19 |
4.3 Market Restraints |
4.3.1 Fluctuating travel restrictions impacting tourist arrivals |
4.3.2 Limited healthcare resources and facilities in certain regions of the Bahamas |
4.3.3 Public hesitancy towards COVID-19 testing and vaccination |
5 Bahamas COVID-19 Infection Market Trends |
6 Bahamas COVID-19 Infection Market, By Types |
6.1 Bahamas COVID-19 Infection Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Bahamas COVID-19 Infection Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Bahamas COVID-19 Infection Market Revenues & Volume, By Omicron, 2021- 2031F |
6.1.4 Bahamas COVID-19 Infection Market Revenues & Volume, By Delta, 2021- 2031F |
6.1.5 Bahamas COVID-19 Infection Market Revenues & Volume, By Gamma, 2021- 2031F |
6.1.6 Bahamas COVID-19 Infection Market Revenues & Volume, By Beta, 2021- 2031F |
6.1.7 Bahamas COVID-19 Infection Market Revenues & Volume, By Alpha, 2021- 2031F |
6.2 Bahamas COVID-19 Infection Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Bahamas COVID-19 Infection Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Bahamas COVID-19 Infection Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.2.4 Bahamas COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Bahamas COVID-19 Infection Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Bahamas COVID-19 Infection Market Revenues & Volume, By Swab Test, 2021- 2031F |
6.3.3 Bahamas COVID-19 Infection Market Revenues & Volume, By Antibody Test, 2021- 2031F |
6.3.4 Bahamas COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Bahamas COVID-19 Infection Market, By Dosage Forms |
6.4.1 Overview and Analysis |
6.4.2 Bahamas COVID-19 Infection Market Revenues & Volume, By Capsule, 2021- 2031F |
6.4.3 Bahamas COVID-19 Infection Market Revenues & Volume, By Tablets, 2021- 2031F |
6.4.4 Bahamas COVID-19 Infection Market Revenues & Volume, By Injections, 2021- 2031F |
6.4.5 Bahamas COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Bahamas COVID-19 Infection Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Bahamas COVID-19 Infection Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Bahamas COVID-19 Infection Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 Bahamas COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Bahamas COVID-19 Infection Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Bahamas COVID-19 Infection Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Bahamas COVID-19 Infection Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Bahamas COVID-19 Infection Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 Bahamas COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Bahamas COVID-19 Infection Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Bahamas COVID-19 Infection Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Bahamas COVID-19 Infection Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Bahamas COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Bahamas COVID-19 Infection Market Revenues & Volume, By Others, 2021- 2031F |
7 Bahamas COVID-19 Infection Market Import-Export Trade Statistics |
7.1 Bahamas COVID-19 Infection Market Export to Major Countries |
7.2 Bahamas COVID-19 Infection Market Imports from Major Countries |
8 Bahamas COVID-19 Infection Market Key Performance Indicators |
8.1 Percentage of population tested for COVID-19 regularly |
8.2 Number of healthcare facilities offering COVID-19 testing services |
8.3 Percentage of population vaccinated against COVID-19 |
8.4 Rate of positive COVID-19 cases in the Bahamas |
8.5 Availability and distribution of COVID-19 testing kits in the market |
9 Bahamas COVID-19 Infection Market - Opportunity Assessment |
9.1 Bahamas COVID-19 Infection Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Bahamas COVID-19 Infection Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Bahamas COVID-19 Infection Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Bahamas COVID-19 Infection Market Opportunity Assessment, By Dosage Forms, 2021 & 2031F |
9.5 Bahamas COVID-19 Infection Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Bahamas COVID-19 Infection Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Bahamas COVID-19 Infection Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Bahamas COVID-19 Infection Market - Competitive Landscape |
10.1 Bahamas COVID-19 Infection Market Revenue Share, By Companies, 2024 |
10.2 Bahamas COVID-19 Infection Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here